Skip to content
Get alerts
GovInfoNow
Lower risk Drug recall · FDA · Published February 25, 2025

A-S Medication Solutions Recalls Metformin Extended-Release Tablets Due to Foreign Tablets

A-S Medication Solutions recalls metformin extended-release tablets (500mg, 180 tablets) due to foreign tablets present in some lots. Consumers should check product details and contact the company for guidance.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0292-2025DrugA-S Medication Solutions ›
Take action

Contact the company

Recalling firmA-S Medication Solutions LLC2401 Commerce Dr · Libertyville, IL 60048-4464
✎ GovInfoNow plain-language explainer

A-S Medication Solutions has recalled metformin extended-release tablets (500mg, 180 tablets) because foreign tablets or capsules were found in some batches. This could lead to unintended medication intake if the foreign items are consumed. Read more at govinfonow.com/recall/32264-a-s-medication-solutions-recalls-metformin-extended-release-tablets-due.

Source Summary by GovInfoNow · govinfonow.com/recall/32264-a-s-medication-solutions-recalls-metformin-extended-release-tablets-due · Updated August 17, 2026 · FDA enforcement record: FDA #D-0292-2025

Cite this page

“A-S Medication Solutions Recalls Metformin Extended-Release Tablets Due to Foreign Tablets.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32264-a-s-medication-solutions-recalls-metformin-extended-release-tablets-due. Based on FDA recall #D-0292-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0292-2025%22&limit=1).

The FDA announced on Feb. 25, 2025, that A-S Medication Solutions LLC is voluntarily recalling Metformin Hydrochloride Extended-Release tablets due to the presence of foreign tablets or capsules. Owners should stop using the product and contact the company for a refund.

How to tell if you have it

  • Brand: A-S Medication Solutions
  • Product: METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS
  • NDC: 50090-1494-3
  • Lot#: 4260340
  • Expiration: 12/31/2025
  • Quantity: 411 bottles of 180 tablets

The hazard

The recall is due to the presence of foreign tablets or capsules in the Metformin Hydrochloride Extended-Release bottles. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show A-S Medication Solutions LLC has issued five other recalls since April 22, 2016. Recent similar product recalls include the Golden State Baclofen Tablets Recall on Nov. 26, 2025, and the Bionpharma Divalproex Tablets Recall on June 26, 2026, both citing foreign tablet risks.

How to tell if you have this one

Check for the product name 'Metformin Hydrochloride Extended-Release 500mg, 180 tablets' and the lot number 4260340 on the packaging. The expiration date is December 31, 2025.

  • Brand
    A-S Medication Solutions
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot number 4260340 and expiration date of December 31, 2025 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 36 days after the firm started it.

1. Firm started the recall: Feb 25, 202512. FDA classified it Class II: Mar 21, 202523. Published in FDA’s Enforcement Report: Apr 2, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Teva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva PharmaceuticalsAmerican Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0292-2025 (February 25, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0292-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA